Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5-hydroxytryptamine 2B receptor (5-HT2B receptor) is a G protein-coupled receptor that belongs to the serotonin receptor family. It is involved in various physiological processes, including cardiovascular function, neurotransmitter regulation, and cell cycle progression. Dysregulation of this receptor is implicated in diseases such as cardiac valvulopathy, pulmonary hypertension, psychiatric disorders, and cancer. Several drugs acting on this receptor have been withdrawn due to safety concerns regarding valvular heart disease.
Activation of Gq proteins leading to increased intracellular calcium and downstream signaling cascades (e.g., MAPK/ERK). Modulation of serotonin transporter function. β-arrestin recruitment.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5-Hydroxytryptamine 2B Receptor (5-HT2B Receptor).